Flore by Sun Genomics
Convertible Note in 2024
Sun Genomics, Inc. is a microbiome health company based in San Diego, California, specializing in customized probiotics aimed at addressing dysbiosis. Founded in 2014, the company’s flagship product, Floré, combines a gut microbiome test with personalized probiotic formulations tailored to individual gut profiles, assessed through whole-genome sequencing. The Floré Gut Test includes a microflora collection kit, a comprehensive microflora profile analysis, and wellness consultations. Additionally, Sun Genomics offers Floré Tots, a probiotic solution designed for children up to age 12, which comes in a convenient powder form that can be easily mixed with beverages. The company sells its products online, providing an automatic renewal service to enhance customer convenience.
heXem bio
Seed Round in 2024
heXem bio specializes in recording solutions for the early development of humans for longevity.
Flore by Sun Genomics
Series B in 2023
Sun Genomics, Inc. is a microbiome health company based in San Diego, California, specializing in customized probiotics aimed at addressing dysbiosis. Founded in 2014, the company’s flagship product, Floré, combines a gut microbiome test with personalized probiotic formulations tailored to individual gut profiles, assessed through whole-genome sequencing. The Floré Gut Test includes a microflora collection kit, a comprehensive microflora profile analysis, and wellness consultations. Additionally, Sun Genomics offers Floré Tots, a probiotic solution designed for children up to age 12, which comes in a convenient powder form that can be easily mixed with beverages. The company sells its products online, providing an automatic renewal service to enhance customer convenience.
Mimio Health is a nutraceutical company dedicated to the research and development of fasting mimetic supplements. The company has created a patent-pending formulation that utilizes a carefully chosen blend of bioactive human metabolites designed to mimic the body's natural response to fasting. This innovative approach aims to replicate the cellular health benefits associated with fasting, enabling users to experience anti-inflammatory and antioxidant effects that may help combat age-related chronic inflammation and cellular damage, without the need for actual fasting. Through its scientific research, Mimio Health seeks to enhance overall wellness and longevity.
BiomeSense
Seed Round in 2023
BiomeSense, Inc. is a Chicago-based company founded in 2018 that focuses on developing a comprehensive platform for microbiome data collection and analysis. Its primary innovation is the GutLab, a "smart bathroom" system designed for continuous, at-home monitoring of the human gut microbiome. This technology is integrated with the MetaBiome time-series analytics platform, offering a seamless end-to-end solution that enables real-time tracking of microbiome changes and their correlation with clinical outcomes. By generating and analyzing extensive longitudinal microbiome datasets, BiomeSense aims to discover and commercialize novel microbiome biomarkers, providing healthcare professionals with a high-resolution microbiome database. This resource supports the development of advanced microbiome-based therapeutics and consumer products, ultimately enhancing precision medicine and improving health outcomes.
Aluna is a healthcare company based in San Francisco, California, founded in 2013, that specializes in developing a portable spirometry device aimed at improving the management of asthma. The company's innovative solution combines a spirometer with an interactive mobile application, allowing patients to monitor their asthma symptoms effectively. Through daily measurements and the use of machine learning, Aluna empowers patients and their parents to understand their respiratory conditions better and take control of their lung health. The platform provides real-time data that can be shared with healthcare providers, enabling early detection of asthma attacks and informed decision-making regarding personalized treatment plans. Aluna aims to enhance the quality of life for individuals with chronic respiratory conditions through its advanced technology and data-driven insights.
Flore by Sun Genomics
Series B in 2022
Sun Genomics, Inc. is a microbiome health company based in San Diego, California, specializing in customized probiotics aimed at addressing dysbiosis. Founded in 2014, the company’s flagship product, Floré, combines a gut microbiome test with personalized probiotic formulations tailored to individual gut profiles, assessed through whole-genome sequencing. The Floré Gut Test includes a microflora collection kit, a comprehensive microflora profile analysis, and wellness consultations. Additionally, Sun Genomics offers Floré Tots, a probiotic solution designed for children up to age 12, which comes in a convenient powder form that can be easily mixed with beverages. The company sells its products online, providing an automatic renewal service to enhance customer convenience.
Aima is a Vancouver-based company founded in 2019 that focuses on transforming the management of menstrual pain. The company provides a weekly proactive pain management system designed specifically for menstruators, offering personalized and effective solutions to address period pain. Aima's platform aims to empower users by enabling them to manage their pain with greater freedom and dignity. Through its innovative approach, Aima seeks to improve the overall experience of menstruators by providing accessible and tailored pain relief options.
Proton Intelligence
Seed Round in 2022
Proton Intelligence, founded in 2020 and headquartered in Vancouver, Canada, specializes in biomarker monitoring to manage chronic diseases and enhance patient outcomes. The company focuses on continuous potassium monitoring, particularly for patients suffering from hyperkalemia associated with chronic kidney disease and other co-morbidities. Proton Intelligence's innovative platform provides accurate and real-time potassium measurements through interstitial fluid analysis, which correlates closely with blood levels. This capability is critical for enabling timely and informed decision-making regarding patient care, allowing clinicians and patients to effectively manage medications, dietary choices, and treatment options. By prioritizing precise monitoring, Proton Intelligence aims to significantly improve the health and lives of individuals affected by hyperkalemia.
Nourie Hair
Seed Round in 2022
Nourie hair provides the scalp and strands with a special nourishing component to heal hair and scalp damage.
Ria Health
Series A in 2022
Ria Health is an online platform that provides telehealth services aimed at helping individuals modify their relationship with alcohol. It offers personalized treatment plans that include medication-assisted options and behavioral therapies, all facilitated by licensed healthcare professionals. The platform emphasizes continuous monitoring to help users track their progress and maintain accountability. Ria Health also features a mobile app that provides access to educational materials, support groups, and communication with care teams. This comprehensive approach is designed to assist users in managing alcohol consumption and fostering healthier habits, ultimately addressing the challenges associated with alcohol use disorder.
BioLumen
Convertible Note in 2022
BioLumen is a nutritional technology company that develops a patented dietary fiber technology platform that reduces the negative effect of a diet heavy in processed foods. BioLumen's technology is composed of insoluble dietary fiber matrix covered with a blend of food ingredients created from the latest drug delivery system research. The company's product, a nutraceutical, focuses on high risk individuals with prediabetes to help manage blood sugar levels, protect their liver from excess sugar and feed their gut microbiome, delivering health benefits. BioLumen was founded on 2018 and is headquartered in San Francisco, California.
AnimalBiome
Series A in 2022
AnimalBiome specializes in personalized nutrition services that focus on enhancing the gut health of dogs and cats through microbiome science. The company offers microbiome tests that assess the unique gut microbiota of individual pets, providing insights that inform tailored nutrition recommendations. Additionally, AnimalBiome develops restorative supplements made from material sourced from healthy animals, allowing for the introduction of beneficial microbes to help restore balance in the gut microbiome. By leveraging advanced diagnostic tools, including DNA sequencing, AnimalBiome enables pet owners to better understand their pets' gut health, ultimately contributing to improved well-being and a healthier lifestyle for their animals.
Kalia Health
Convertible Note in 2022
Kalia Health is a biotechnology company based in Chapel Hill, North Carolina, founded in 2019. The company focuses on improving maternal health outcomes by developing safe, affordable, and accessible home-based early detection tests for complications during pregnancy. One of its key products is a low-cost, reliable preeclampsia detection strip, which enables expectant mothers to self-screen for this serious condition. By facilitating early detection, Kalia Health aims to empower women to seek timely medical intervention, ultimately reducing the risks associated with preeclampsia and enhancing maternal health.
Eachday
Convertible Note in 2022
Eachday is a Pittsburgh-based digital health management company focused on providing tools and evidence-based techniques for self-managing ADHD. The company offers an ADHD self-management application designed to assist users in effectively managing their daily lives. By tracking behaviors and interests, such as task completion, cognitive failures, and self-reported symptoms, Eachday creates personalized profiles that help users gain insights into their cognitive patterns. This approach enables individuals to visualize their time and develop structured routines, ultimately aiming to alleviate ADHD symptoms as they arise and lessen the cognitive burden associated with everyday activities.
Eachday
Seed Round in 2022
Eachday is a Pittsburgh-based digital health management company focused on providing tools and evidence-based techniques for self-managing ADHD. The company offers an ADHD self-management application designed to assist users in effectively managing their daily lives. By tracking behaviors and interests, such as task completion, cognitive failures, and self-reported symptoms, Eachday creates personalized profiles that help users gain insights into their cognitive patterns. This approach enables individuals to visualize their time and develop structured routines, ultimately aiming to alleviate ADHD symptoms as they arise and lessen the cognitive burden associated with everyday activities.
Kalia Health
Seed Round in 2022
Kalia Health is a biotechnology company based in Chapel Hill, North Carolina, founded in 2019. The company focuses on improving maternal health outcomes by developing safe, affordable, and accessible home-based early detection tests for complications during pregnancy. One of its key products is a low-cost, reliable preeclampsia detection strip, which enables expectant mothers to self-screen for this serious condition. By facilitating early detection, Kalia Health aims to empower women to seek timely medical intervention, ultimately reducing the risks associated with preeclampsia and enhancing maternal health.
Proton Intelligence
Seed Round in 2021
Proton Intelligence, founded in 2020 and headquartered in Vancouver, Canada, specializes in biomarker monitoring to manage chronic diseases and enhance patient outcomes. The company focuses on continuous potassium monitoring, particularly for patients suffering from hyperkalemia associated with chronic kidney disease and other co-morbidities. Proton Intelligence's innovative platform provides accurate and real-time potassium measurements through interstitial fluid analysis, which correlates closely with blood levels. This capability is critical for enabling timely and informed decision-making regarding patient care, allowing clinicians and patients to effectively manage medications, dietary choices, and treatment options. By prioritizing precise monitoring, Proton Intelligence aims to significantly improve the health and lives of individuals affected by hyperkalemia.
Oralta is a United States-based company specializing in the production of probiotic supplements aimed at improving oral health. The company manufactures FRESH BREATH, a line of chewable tablets designed to combat bad breath by targeting odor-producing bacteria. These probiotics work by restoring a healthy balance of beneficial bacteria in the mouth, effectively eliminating the harmful germs responsible for unpleasant odors. In addition to addressing bad breath, Oralta's products also focus on broader oral health issues, such as tooth decay and gum disease. By inactivating the byproducts of these harmful bacteria, Oralta supports sustainable oral hygiene practices, allowing users to maintain their overall dental well-being.
Ria Health
Convertible Note in 2021
Ria Health is an online platform that provides telehealth services aimed at helping individuals modify their relationship with alcohol. It offers personalized treatment plans that include medication-assisted options and behavioral therapies, all facilitated by licensed healthcare professionals. The platform emphasizes continuous monitoring to help users track their progress and maintain accountability. Ria Health also features a mobile app that provides access to educational materials, support groups, and communication with care teams. This comprehensive approach is designed to assist users in managing alcohol consumption and fostering healthier habits, ultimately addressing the challenges associated with alcohol use disorder.
Basin Genomics
Convertible Note in 2021
Basin Genomics is combining scientific backgrounds in genomics and oncology with startup expertise to translate genetic discoveries into advances in personalized clinical care as it strives to develop technology that will decrease the rates of cervical cancer globally.
Basin Genomics
Seed Round in 2021
Basin Genomics is combining scientific backgrounds in genomics and oncology with startup expertise to translate genetic discoveries into advances in personalized clinical care as it strives to develop technology that will decrease the rates of cervical cancer globally.
SEQUENTIAL
Pre Seed Round in 2021
Sequential Skin is a diagnostic platform focused on skin longevity and aging, leveraging expertise in genetics, epigenetics, and the skin microbiome. The company specializes in clinical microbiome testing for skin, scalp, and female health. Its primary offering is a skin health test that employs quantitative real-time PCR (qPCR) technology to analyze specific markers within the skin microbiome. This analysis provides individuals with a detailed understanding of their skin profile, helping them identify their unique skincare needs. By delivering personalized insights, Sequential Skin empowers individuals to make informed decisions about their skincare routines.
Mimio
Convertible Note in 2021
Mimio Health is a nutraceutical company dedicated to the research and development of fasting mimetic supplements. The company has created a patent-pending formulation that utilizes a carefully chosen blend of bioactive human metabolites designed to mimic the body's natural response to fasting. This innovative approach aims to replicate the cellular health benefits associated with fasting, enabling users to experience anti-inflammatory and antioxidant effects that may help combat age-related chronic inflammation and cellular damage, without the need for actual fasting. Through its scientific research, Mimio Health seeks to enhance overall wellness and longevity.
Mimio Health is a nutraceutical company dedicated to the research and development of fasting mimetic supplements. The company has created a patent-pending formulation that utilizes a carefully chosen blend of bioactive human metabolites designed to mimic the body's natural response to fasting. This innovative approach aims to replicate the cellular health benefits associated with fasting, enabling users to experience anti-inflammatory and antioxidant effects that may help combat age-related chronic inflammation and cellular damage, without the need for actual fasting. Through its scientific research, Mimio Health seeks to enhance overall wellness and longevity.
Microgenesis
Convertible Note in 2021
Microgenesis is a biotechnology company focused on fertility and pregnancy health monitoring. It has developed a platform that provides a non-invasive fertility test and personalized nutritional supplementation aimed at restoring women's fertility potential. The company's innovative diagnostic approach detects subclinical inflammation that negatively impacts ovarian function and implantation, specifically targeting women who have experienced challenges, including multiple failed IVF attempts. Operating out of a CLIA lab in Oakland, Microgenesis offers its solutions through OB-GYNs and direct-to-consumer channels. Additionally, the platform addresses imbalances in vaginal and intestinal microbiota linked to infertility and offers dual testing for immunological issues related to the endometrium, equipping patients with effective treatment options for complex reproductive health cases.
EMBER Medical
Convertible Note in 2021
EMBER Medical is a telehealth company based in San Francisco, California, founded in 2018. It develops a mobile application that connects individuals experiencing medical emergencies with nearby healthcare professionals, including physicians, nurses, and emergency medical technicians, within a five-minute radius. The application features in-app audio and video capabilities, allowing users to communicate directly with medical staff for immediate assistance. EMBER Medical aims to enhance the accessibility of healthcare, particularly in underserved areas, by providing a platform that enables patients to receive timely and personalized care without the need for in-person visits. The company's technology also offers healthcare providers various tools to manage virtual consultations effectively.
Stembionix
Seed Round in 2020
Stembionix is a biotechnology company focused on developing advanced longevity products aimed at enhancing both the lifespan and quality of life for individuals. The company specializes in innovative technologies that biologically integrate with users, facilitating a bi-directional exchange of information. This integration allows patients to access their personal stem cells, thereby advancing the field of personalized longevity solutions. Stembionix is dedicated to rapidly advancing its technologies to help individuals live healthier and longer lives.
Stembionix
Convertible Note in 2020
Stembionix is a biotechnology company focused on developing advanced longevity products aimed at enhancing both the lifespan and quality of life for individuals. The company specializes in innovative technologies that biologically integrate with users, facilitating a bi-directional exchange of information. This integration allows patients to access their personal stem cells, thereby advancing the field of personalized longevity solutions. Stembionix is dedicated to rapidly advancing its technologies to help individuals live healthier and longer lives.
BiomeSense
Convertible Note in 2020
BiomeSense, Inc. is a Chicago-based company founded in 2018 that focuses on developing a comprehensive platform for microbiome data collection and analysis. Its primary innovation is the GutLab, a "smart bathroom" system designed for continuous, at-home monitoring of the human gut microbiome. This technology is integrated with the MetaBiome time-series analytics platform, offering a seamless end-to-end solution that enables real-time tracking of microbiome changes and their correlation with clinical outcomes. By generating and analyzing extensive longitudinal microbiome datasets, BiomeSense aims to discover and commercialize novel microbiome biomarkers, providing healthcare professionals with a high-resolution microbiome database. This resource supports the development of advanced microbiome-based therapeutics and consumer products, ultimately enhancing precision medicine and improving health outcomes.
Aluna is a healthcare company based in San Francisco, California, founded in 2013, that specializes in developing a portable spirometry device aimed at improving the management of asthma. The company's innovative solution combines a spirometer with an interactive mobile application, allowing patients to monitor their asthma symptoms effectively. Through daily measurements and the use of machine learning, Aluna empowers patients and their parents to understand their respiratory conditions better and take control of their lung health. The platform provides real-time data that can be shared with healthcare providers, enabling early detection of asthma attacks and informed decision-making regarding personalized treatment plans. Aluna aims to enhance the quality of life for individuals with chronic respiratory conditions through its advanced technology and data-driven insights.
Flore by Sun Genomics
Series A in 2020
Sun Genomics, Inc. is a microbiome health company based in San Diego, California, specializing in customized probiotics aimed at addressing dysbiosis. Founded in 2014, the company’s flagship product, Floré, combines a gut microbiome test with personalized probiotic formulations tailored to individual gut profiles, assessed through whole-genome sequencing. The Floré Gut Test includes a microflora collection kit, a comprehensive microflora profile analysis, and wellness consultations. Additionally, Sun Genomics offers Floré Tots, a probiotic solution designed for children up to age 12, which comes in a convenient powder form that can be easily mixed with beverages. The company sells its products online, providing an automatic renewal service to enhance customer convenience.
BrightCure
Non Equity Assistance in 2020
BrightCure Ltd., established in 2019 and based in London, United Kingdom, specializes in developing probiotic-based therapies aimed at treating urinary tract infections (UTIs). The company focuses on addressing recurrent and difficult-to-treat bacterial infections, a significant health issue affecting 50% of women and 12% of men globally. BrightCure's approach involves utilizing the natural microbiome to reduce harmful bacteria and replenish beneficial bacteria in the vaginal flora, thereby boosting the immune system to promote urinary tract health. The company has garnered recognition through various competitions and accelerators, including selection for Indiebio, the world's largest biotech accelerator.
BrightCure
Seed Round in 2020
BrightCure Ltd., established in 2019 and based in London, United Kingdom, specializes in developing probiotic-based therapies aimed at treating urinary tract infections (UTIs). The company focuses on addressing recurrent and difficult-to-treat bacterial infections, a significant health issue affecting 50% of women and 12% of men globally. BrightCure's approach involves utilizing the natural microbiome to reduce harmful bacteria and replenish beneficial bacteria in the vaginal flora, thereby boosting the immune system to promote urinary tract health. The company has garnered recognition through various competitions and accelerators, including selection for Indiebio, the world's largest biotech accelerator.
Flore by Sun Genomics
Series A in 2020
Sun Genomics, Inc. is a microbiome health company based in San Diego, California, specializing in customized probiotics aimed at addressing dysbiosis. Founded in 2014, the company’s flagship product, Floré, combines a gut microbiome test with personalized probiotic formulations tailored to individual gut profiles, assessed through whole-genome sequencing. The Floré Gut Test includes a microflora collection kit, a comprehensive microflora profile analysis, and wellness consultations. Additionally, Sun Genomics offers Floré Tots, a probiotic solution designed for children up to age 12, which comes in a convenient powder form that can be easily mixed with beverages. The company sells its products online, providing an automatic renewal service to enhance customer convenience.
Sugarlogix
Convertible Note in 2020
Sugarlogix is creating prebiotic sugars with functional benefits for your gut health. Found naturally in human breast milk, their functional sugars restore balance to the gut microbiome, thus enhancing the immune system and reducing inflammation.
EMBER Medical
Seed Round in 2019
EMBER Medical is a telehealth company based in San Francisco, California, founded in 2018. It develops a mobile application that connects individuals experiencing medical emergencies with nearby healthcare professionals, including physicians, nurses, and emergency medical technicians, within a five-minute radius. The application features in-app audio and video capabilities, allowing users to communicate directly with medical staff for immediate assistance. EMBER Medical aims to enhance the accessibility of healthcare, particularly in underserved areas, by providing a platform that enables patients to receive timely and personalized care without the need for in-person visits. The company's technology also offers healthcare providers various tools to manage virtual consultations effectively.
BioLumen
Seed Round in 2019
BioLumen is a nutritional technology company that develops a patented dietary fiber technology platform that reduces the negative effect of a diet heavy in processed foods. BioLumen's technology is composed of insoluble dietary fiber matrix covered with a blend of food ingredients created from the latest drug delivery system research. The company's product, a nutraceutical, focuses on high risk individuals with prediabetes to help manage blood sugar levels, protect their liver from excess sugar and feed their gut microbiome, delivering health benefits. BioLumen was founded on 2018 and is headquartered in San Francisco, California.
Stembionix
Pre Seed Round in 2019
Stembionix is a biotechnology company focused on developing advanced longevity products aimed at enhancing both the lifespan and quality of life for individuals. The company specializes in innovative technologies that biologically integrate with users, facilitating a bi-directional exchange of information. This integration allows patients to access their personal stem cells, thereby advancing the field of personalized longevity solutions. Stembionix is dedicated to rapidly advancing its technologies to help individuals live healthier and longer lives.
Flore by Sun Genomics
Convertible Note in 2019
Sun Genomics, Inc. is a microbiome health company based in San Diego, California, specializing in customized probiotics aimed at addressing dysbiosis. Founded in 2014, the company’s flagship product, Floré, combines a gut microbiome test with personalized probiotic formulations tailored to individual gut profiles, assessed through whole-genome sequencing. The Floré Gut Test includes a microflora collection kit, a comprehensive microflora profile analysis, and wellness consultations. Additionally, Sun Genomics offers Floré Tots, a probiotic solution designed for children up to age 12, which comes in a convenient powder form that can be easily mixed with beverages. The company sells its products online, providing an automatic renewal service to enhance customer convenience.
Guided Clarity
Seed Round in 2019
Guided Clarity, Inc., established in 2018 and headquartered in San Francisco, California, specializes in the development and manufacturing of bioactive peptides designed to enhance mitochondrial health. The company focuses on creating medical food products that isolate specific bioactive proteins known for their mitochondrial renewing properties, targeting the aging population.
BiomeSense
Seed Round in 2019
BiomeSense, Inc. is a Chicago-based company founded in 2018 that focuses on developing a comprehensive platform for microbiome data collection and analysis. Its primary innovation is the GutLab, a "smart bathroom" system designed for continuous, at-home monitoring of the human gut microbiome. This technology is integrated with the MetaBiome time-series analytics platform, offering a seamless end-to-end solution that enables real-time tracking of microbiome changes and their correlation with clinical outcomes. By generating and analyzing extensive longitudinal microbiome datasets, BiomeSense aims to discover and commercialize novel microbiome biomarkers, providing healthcare professionals with a high-resolution microbiome database. This resource supports the development of advanced microbiome-based therapeutics and consumer products, ultimately enhancing precision medicine and improving health outcomes.
Flore by Sun Genomics
Venture Round in 2019
Sun Genomics, Inc. is a microbiome health company based in San Diego, California, specializing in customized probiotics aimed at addressing dysbiosis. Founded in 2014, the company’s flagship product, Floré, combines a gut microbiome test with personalized probiotic formulations tailored to individual gut profiles, assessed through whole-genome sequencing. The Floré Gut Test includes a microflora collection kit, a comprehensive microflora profile analysis, and wellness consultations. Additionally, Sun Genomics offers Floré Tots, a probiotic solution designed for children up to age 12, which comes in a convenient powder form that can be easily mixed with beverages. The company sells its products online, providing an automatic renewal service to enhance customer convenience.
Oralta is a United States-based company specializing in the production of probiotic supplements aimed at improving oral health. The company manufactures FRESH BREATH, a line of chewable tablets designed to combat bad breath by targeting odor-producing bacteria. These probiotics work by restoring a healthy balance of beneficial bacteria in the mouth, effectively eliminating the harmful germs responsible for unpleasant odors. In addition to addressing bad breath, Oralta's products also focus on broader oral health issues, such as tooth decay and gum disease. By inactivating the byproducts of these harmful bacteria, Oralta supports sustainable oral hygiene practices, allowing users to maintain their overall dental well-being.
Sugarlogix
Seed Round in 2018
Sugarlogix is creating prebiotic sugars with functional benefits for your gut health. Found naturally in human breast milk, their functional sugars restore balance to the gut microbiome, thus enhancing the immune system and reducing inflammation.
Clinicai
Seed Round in 2018
CLINICAI Inc. is a health technology company based in San Francisco, California, that focuses on developing innovative solutions for health monitoring within the bathroom environment. Founded in 2016, CLINICAI creates smart toilet devices equipped with a network of sensors and artificial intelligence to non-invasively track health indicators, particularly for wellness and the early detection of gastrointestinal cancers and diseases. The company's technology offers a monitoring platform that integrates connected devices to gather and analyze health data related to urinary and stool samples. This approach enables individuals to detect potential health issues at an early stage, empowering them to address preventable disorders effectively.
EMBER Medical
Seed Round in 2018
EMBER Medical is a telehealth company based in San Francisco, California, founded in 2018. It develops a mobile application that connects individuals experiencing medical emergencies with nearby healthcare professionals, including physicians, nurses, and emergency medical technicians, within a five-minute radius. The application features in-app audio and video capabilities, allowing users to communicate directly with medical staff for immediate assistance. EMBER Medical aims to enhance the accessibility of healthcare, particularly in underserved areas, by providing a platform that enables patients to receive timely and personalized care without the need for in-person visits. The company's technology also offers healthcare providers various tools to manage virtual consultations effectively.
Mouth2Mouth
Seed Round in 2018
Mouth2Mouth is a healthcare startup that develops personalized probiotics for oral health. Based on microbiome data from thousands of healthy individuals, their AI-driven platform determines consortia of beneficial bacteria that fight widespread conditions such as tooth decay, gum disease, and bad breath. The company is on a mission to improve oral hygiene and provide a solution to oral diseases by use of an all-natural process.
Flore by Sun Genomics
Seed Round in 2017
Sun Genomics, Inc. is a microbiome health company based in San Diego, California, specializing in customized probiotics aimed at addressing dysbiosis. Founded in 2014, the company’s flagship product, Floré, combines a gut microbiome test with personalized probiotic formulations tailored to individual gut profiles, assessed through whole-genome sequencing. The Floré Gut Test includes a microflora collection kit, a comprehensive microflora profile analysis, and wellness consultations. Additionally, Sun Genomics offers Floré Tots, a probiotic solution designed for children up to age 12, which comes in a convenient powder form that can be easily mixed with beverages. The company sells its products online, providing an automatic renewal service to enhance customer convenience.
Sugarlogix
Seed Round in 2017
Sugarlogix is creating prebiotic sugars with functional benefits for your gut health. Found naturally in human breast milk, their functional sugars restore balance to the gut microbiome, thus enhancing the immune system and reducing inflammation.
AnimalBiome
Seed Round in 2016
AnimalBiome specializes in personalized nutrition services that focus on enhancing the gut health of dogs and cats through microbiome science. The company offers microbiome tests that assess the unique gut microbiota of individual pets, providing insights that inform tailored nutrition recommendations. Additionally, AnimalBiome develops restorative supplements made from material sourced from healthy animals, allowing for the introduction of beneficial microbes to help restore balance in the gut microbiome. By leveraging advanced diagnostic tools, including DNA sequencing, AnimalBiome enables pet owners to better understand their pets' gut health, ultimately contributing to improved well-being and a healthier lifestyle for their animals.
Ria Health
Pre Seed Round in 2016
Ria Health is an online platform that provides telehealth services aimed at helping individuals modify their relationship with alcohol. It offers personalized treatment plans that include medication-assisted options and behavioral therapies, all facilitated by licensed healthcare professionals. The platform emphasizes continuous monitoring to help users track their progress and maintain accountability. Ria Health also features a mobile app that provides access to educational materials, support groups, and communication with care teams. This comprehensive approach is designed to assist users in managing alcohol consumption and fostering healthier habits, ultimately addressing the challenges associated with alcohol use disorder.
Perennial
Seed Round in 2016
At Perennial, we believe in living healthier and thriving at any age. Our mission is to champion and enhance the lives of those who are Greater than 50 – by harnessing the power and potential of plant-based ingredients and developing solutions tailor-made for longevity in health. Through relentless innovation, we strive to reimagine adult nutrition across the globe and prepare our world for a generation of people redefining what it means to be Greater than 50.
Aluna is a healthcare company based in San Francisco, California, founded in 2013, that specializes in developing a portable spirometry device aimed at improving the management of asthma. The company's innovative solution combines a spirometer with an interactive mobile application, allowing patients to monitor their asthma symptoms effectively. Through daily measurements and the use of machine learning, Aluna empowers patients and their parents to understand their respiratory conditions better and take control of their lung health. The platform provides real-time data that can be shared with healthcare providers, enabling early detection of asthma attacks and informed decision-making regarding personalized treatment plans. Aluna aims to enhance the quality of life for individuals with chronic respiratory conditions through its advanced technology and data-driven insights.
Nerd Skincare
Seed Round in 2015
Nerd Skincare Inc., established in 2015 and based in Elmhurst, New York, specializes in manufacturing and supplying skincare products under its NERD brand. The company offers a range of products including acne treatment systems, nourishing creams, clarifying cleansers, and advanced cellular intelligence systems designed to postpone signs of aging. Notably, Nerd Skincare has developed bacterial cellulose sheets that can accelerate chronic wound healing by approximately 40%, with plans to offer these at a significantly reduced price compared to current market alternatives. The company primarily markets its products online, making them accessible to customers worldwide.
Ranomics
Pre Seed Round in 2015
Ranomics Inc., established in 2015 with headquarters in San Francisco and a location in Toronto, specializes in providing a comprehensive database of rare genetic variations and their associated disease risks. The company offers RanomicsDB, a query interface supporting VCF files, and Ranomics API, enabling integration of variant interpretation data into existing pipelines for software companies. Founded by Leo Wan and Cathy Tie, Ranomics aims to enhance understanding of human genetics through its services, facilitating cost-effective and efficient genetic variation analysis for healthcare professionals.